G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination

BACKGROUND: Glucose 6-phosphate dehydrogenase deficiency (G6PDd) plays a central role in readiness assessment for malaria elimination in Myanmar by 2030 that includes primaquine (PQ) use. The risk of hemolysis in G6PDd individuals hampers the widespread use of primaquine safely in malaria-infected p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Trop Med Health
Päätekijät: Han, Kay Thwe, Han, Zay Yar, Aye, Kyin Hla, Wai, Khin Thet, Thi, Aung, Cui, Liwang, Sattabongkot, Jetsumon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191138/
https://ncbi.nlm.nih.gov/pubmed/34108049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41182-021-00339-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia